US Patent Issued to Regeneron Pharmaceuticals on Jan. 13 for "IL12 receptor agonists and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,638, issued on Jan. 13, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"IL12 receptor agonists and methods of use thereof" was invented by Aaron Chang (White Plains, N.Y.), Jiaxi Wu (Elmsford, N.Y.), Tong Zhang (New Rochelle, N.Y.), Nicolin Bloch (Ossining, N.Y.), Erica Ullman (Yorktown Heights, N.Y.), Eric Smith (New York), Chia-Yang Lin (Scarsdale, N.Y.) and Samuel Davis (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to IL12 receptor agonists with improved therapeutic profiles."

The patent was filed on July 18, 2022, under Application No. 17/813,122.

*For further information, including ...